179337-70-3

Basic information

• Product Name: 2(S)-Amino-6-(1-iminoethylamino)-N-(1H-tetrazol-5-yl)hexanamide dihydrochloride
• Synonyms: L-NIL-TA; SC-51; N6-(1-Iminoethyl)-N1-(1H-tetrazol-5-yl)-L-lysinamide dihydrochloride
• CAS NO: 179337-70-3
• Molecular Formula: C₉H₂₀Cl₂N₈O
• Molecular Weight: 327.21875
• Mol File: 179337-70-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2(S)-Amino-6-(1-iminoethylamino)-N-(1H-tetrazol-5-yl)hexanamide dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2(S)-Amino-6-(1-iminoethylamino)-N-(1H-tetrazol-5-yl)hexanamide dihydrochloride(179337-70-3)
• EPA Substance Registry System: 2(S)-Amino-6-(1-iminoethylamino)-N-(1H-tetrazol-5-yl)hexanamide dihydrochloride(179337-70-3)

Safety Data

• Hazardous Substances Data: 179337-70-3(Hazardous Substances Data)

Upstream product

• 2389-45-9 Boc-Lys(Z)-OH 
• 218783-53-0 phenylmethyl (5S)-5-[[[(1,1-dimethylethoxy)carbonyl]amino]-6-oxo-6-(1H-tetrazol-5-ylamino)hexyl]carbamate 

Relevant articles and documents

COMBINATION THERAPY WITH INHIBITORS OF INDUCIBLE NITRIC OXIDE SYNTHASE AND ALKYLATING AGENTS

A combination therapy comprising administration of a carbamoylating chemotherapeutic agent in conjunction with administration of a selective iNOS inhibitor compound is disclosed. Optionally, resection and radiation therapy are provided with the therapeutic combination. A medicament comprising a carbamoylating chemotherapeutic agent and a selective iNOS inhibitor compound together with a pharmaceutically acceptable carrier is further disclosed. A kit comprising a carbamoylating chemotherapeutic agent and a selective iNOS inhibitor compound is further disclosed.